» Articles » PMID: 35127151

Extracellular Vesicles from Mycoplasmas Can Penetrate Eukaryotic Cells In Vitro and Modulate the Cellular Proteome

Overview
Journal Acta Naturae
Specialty Biology
Date 2022 Feb 7
PMID 35127151
Authors
Affiliations
Soon will be listed here.
Abstract

The extracellular vesicles (EVs) produced by bacteria transport a wide range of compounds, including proteins, DNA and RNA, mediate intercellular interactions, and may be important participants in the mechanisms underlying the persistence of infectious agents. This study focuses on testing the hypothesis that the EVs of mycoplasmas, the smallest prokaryotes capable of independent reproduction, combined in the class referred to as Mollicutes, can penetrate into eukaryotic cells and modulate their immunoreactivity. To verify this hypothesis, for the first time, studies of in vitro interaction between human skin fibroblasts and vesicles isolated from Acholeplasma laidlawii (the ubiquitous mycoplasma that infects higher eukaryotes and is the main contaminant of cell cultures and vaccines) were conducted using confocal laser scanning microscopy and proteome profiling, employing a combination of 2D-DIGE and MALDI-TOF/TOF, the Mascot mass-spectrum analysis software and the DAVID functional annotation tool. These studies have revealed for the first time that the extracellular vesicles of A. laidlawii can penetrate into eukaryotic cells in vitro and modulate the expression of cellular proteins. The molecular mechanisms behind the interaction of mycoplasma vesicles with eukaryotic cells and the contribution of the respective nanostructures to the molecular machinery of cellular permissiveness still remain to be elucidated. The study of these aspects is relevant both for fundamental research into the "logic of life" of the simplest prokaryotes, and the practical development of efficient control over hypermutable bacteria infecting humans, animals and plants, as well as contaminating cell cultures and vaccines.

References
1.
Zhang Y, Liu Y, Liu H, Tang W . Exosomes: biogenesis, biologic function and clinical potential. Cell Biosci. 2019; 9:19. PMC: 6377728. DOI: 10.1186/s13578-019-0282-2. View

2.
Poli G, Ceni E, Armignacco R, Ercolino T, Canu L, Baroni G . 2D-DIGE proteomic analysis identifies new potential therapeutic targets for adrenocortical carcinoma. Oncotarget. 2015; 6(8):5695-706. PMC: 4467395. DOI: 10.18632/oncotarget.3299. View

3.
Chernov V, Chernova O, Mouzykantov A, Medvedeva E, Baranova N, Malygina T . Antimicrobial resistance in mollicutes: known and newly emerging mechanisms. FEMS Microbiol Lett. 2018; 365(18). DOI: 10.1093/femsle/fny185. View

4.
Hopfe M, Deenen R, Degrandi D, Kohrer K, Henrich B . Host cell responses to persistent mycoplasmas--different stages in infection of HeLa cells with Mycoplasma hominis. PLoS One. 2013; 8(1):e54219. PMC: 3543322. DOI: 10.1371/journal.pone.0054219. View

5.
Chernov V, Chernova O, Mouzykantov A, Lopukhov L, Aminov R . Omics of antimicrobials and antimicrobial resistance. Expert Opin Drug Discov. 2019; 14(5):455-468. DOI: 10.1080/17460441.2019.1588880. View